Mirum Pharmaceuticals
MIRM
160 hedge funds and large institutions have $1.82B invested in Mirum Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 66 increasing their positions, 48 reducing their positions, and 35 closing their positions.
125% more funds holding in top 10
Funds holding in top 10: 4 → 9 (+5)
49% more call options, than puts
Call options by funds: $3.64M | Put options by funds: $2.44M
38% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 48
36% more capital invested
Capital invested by funds: $1.34B → $1.82B (+$487M)
0.98% less ownership
Funds ownership: 114.11% → 113.13% (-0.98%)
6% less funds holding
Funds holding: 171 → 160 (-11)
29% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 35
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
+$58.2M |
| 2 |
BlackRock
New York
|
+$20.6M |
| 3 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$13.3M |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$12.9M |
| 5 |
ClearBridge Investments
New York
|
+$11.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$34.8M |
| 2 |
CCM
Cadian Capital Management
New York
|
-$27.7M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$10.8M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$10.4M |
| 5 |
CC
Checkpoint Capital
San Francisco,
California
|
-$9.1M |
MIRM Hedge Fund Activity: Q2 2024 in Review
160 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q2 2024, worth a combined $1.82B — up 36% from $1.34B a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of MIRM and 25 opened new positions — a net loss of 10 holders — while 48 trimmed existing stakes and 66 added.
The largest buyer was Janus Henderson Group, adding an estimated $58.2M. The largest seller was State Street, cutting an estimated $34.8M.
- 160 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q2 2024, down from 171 in Q1 2024.
- Funds reported $1.82B of Mirum Pharmaceuticals stock for Q2 2024, up 36% quarter-over-quarter.
- 25 funds opened new Mirum Pharmaceuticals positions in Q2 2024 and 35 closed out, a net change of -10 holders.
- The largest Mirum Pharmaceuticals buyer in Q2 2024 was Janus Henderson Group, an estimated $58.2M added.
- The largest Mirum Pharmaceuticals seller in Q2 2024 was State Street, an estimated $34.8M sold.
Based on aggregated 13F filings for Q2 2024.